APOE genotype strengthened the prognostic value of plasma p-tau217 for cognitive impairment in a pooled study of 8,582 adults ...
Combining a genetic test to identify APOE variant carriers with a blood test measuring the biomarker p-tau217 may help to more effectively identify those who may benefit from closer monitoring for ...
Please provide your email address to receive an email when new articles are posted on . When using SAGE, PCPs documented new cognitive conditions six times as often. The tool’s developer highlighted ...
A new generation of blood tests is making it easier for doctors to look for biological signs of Alzheimer’s disease, ...
It is the first test the FDA has cleared for use in symptomatic adults aged 40 and over, according to C2N Diagnostics.
PrecivityAD2 is cleared for adults ≥40 with cognitive impairment symptoms and is intended to complement, not replace, standard diagnostic evaluation incorporating history, exam, cognitive testing, ...
Please provide your email address to receive an email when new articles are posted on . PHILADELPHIA — A computerized cognitive battery was effective in detecting cognitive impairment and amyloid ...
In patients who present with cognitive concerns, the clinical judgment of primary care physicians is sensitive, but not specific, when used to screen for any cognitive impairment. It is specific, but ...
A cognitive test is a required part of the Medicare annual wellness visit (AWV). This can be a valuable tool in discovering specific cognitive health conditions early, like dementia and Alzheimer’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results